Fig. 1From: Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective studyThe median survival time following radiotherapy with three-dimensional conformal radiation therapy was 17 months (range, 1–64 months), and the estimated 3-year survival rate was 38 %Back to article page